174 related articles for article (PubMed ID: 1816322)
21. Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of cholesterol, sitosterol, and lovastatin.
Nguyen LB; Shefer S; Salen G; Tint GS; Ruiz F; Bullock J
J Lipid Res; 2001 Feb; 42(2):195-200. PubMed ID: 11181748
[TBL] [Abstract][Full Text] [Related]
22. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
[TBL] [Abstract][Full Text] [Related]
23. Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.
Hagemenas FC; Illingworth DR
Arteriosclerosis; 1989; 9(3):355-61. PubMed ID: 2719596
[TBL] [Abstract][Full Text] [Related]
24. Hyperabsorption and retention of campestanol in a sitosterolemic homozygote: comparison with her mother and three control subjects.
Salen G; Xu G; Tint GS; Batta AK; Shefer S
J Lipid Res; 2000 Nov; 41(11):1883-9. PubMed ID: 11060358
[TBL] [Abstract][Full Text] [Related]
25. In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Decreased enzyme catalytic efficiency in familial hypercholesterolemia.
Stacpoole PW; Bridge DM; Alvarez IM; Goldberg RB; Harwood HJ
J Clin Invest; 1987 Nov; 80(5):1401-8. PubMed ID: 2824560
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human leukocytes.
Fogelman AM; Seager J; Edwards PA; Popják G
J Biol Chem; 1977 Jan; 252(2):644-51. PubMed ID: 833148
[TBL] [Abstract][Full Text] [Related]
27. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis.
Gregg RE; Connor WE; Lin DS; Brewer HB
J Clin Invest; 1986 Jun; 77(6):1864-72. PubMed ID: 3711338
[TBL] [Abstract][Full Text] [Related]
28. Hepatic low density lipoprotein receptors, HMG-CoA reductase, and plasma lipids and apolipoproteins in high- and low-responding rhesus monkeys: effect of cholestyramine treatment.
Dory L; Bhattacharyya A; Strong J; Chappuis C
J Lipid Res; 1990 Feb; 31(2):279-87. PubMed ID: 2324647
[TBL] [Abstract][Full Text] [Related]
29. Inverse relationship between plasma cholestanol concentrations and bile acid synthesis in sitosterolemia.
Salen G; Batta AK; Tint GS; Shefer S; Ness GC
J Lipid Res; 1994 Oct; 35(10):1878-87. PubMed ID: 7852865
[TBL] [Abstract][Full Text] [Related]
30. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis.
Salen G; Shore V; Tint GS; Forte T; Shefer S; Horak I; Horak E; Dayal B; Nguyen L; Batta AK
J Lipid Res; 1989 Sep; 30(9):1319-30. PubMed ID: 2600539
[TBL] [Abstract][Full Text] [Related]
31. Intestinal HMG-CoA reductase activity is low in hypercholesterolemic patients and is further decreased with lovastatin therapy.
Freeman ML; Prigge WF; Hunninghake DB; Duane WC; Gebhard RL
J Lipid Res; 1988 Jul; 29(7):839-45. PubMed ID: 3411244
[TBL] [Abstract][Full Text] [Related]
32. Effects of an HMG-CoA reductase inhibitor, pravastatin, and bile sequestering resin, cholestyramine, on plasma plant sterol levels in hypercholesterolemic subjects.
Hidaka H; Kojima H; Kawabata T; Nakamura T; Konaka K; Kashiwagi A; Kikkawa R; Shigeta Y
J Atheroscler Thromb; 1995; 2(1):60-5. PubMed ID: 9225210
[TBL] [Abstract][Full Text] [Related]
33. Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and lovastatin.
Yokoyama S; McCoy E
J Inherit Metab Dis; 1992; 15(2):291-2. PubMed ID: 1528002
[No Abstract] [Full Text] [Related]
34. The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway.
Scharnagl H; Schliack M; Löser R; Nauck M; Gierens H; Jeck N; Wieland H; Gross W; März W
Atherosclerosis; 2000 Nov; 153(1):69-80. PubMed ID: 11058701
[TBL] [Abstract][Full Text] [Related]
35. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis.
Salen G; Horak I; Rothkopf M; Cohen JL; Speck J; Tint GS; Shore V; Dayal B; Chen T; Shefer S
J Lipid Res; 1985 Sep; 26(9):1126-33. PubMed ID: 4067433
[TBL] [Abstract][Full Text] [Related]
36. Sitosterolemia.
Salen G; Patel S; Batta AK
Cardiovasc Drug Rev; 2002; 20(4):255-70. PubMed ID: 12481199
[TBL] [Abstract][Full Text] [Related]
37. HMG-CoA reductase is not the site of the primary defect in phytosterolemia.
Berger GM; Pegoraro RJ; Patel SB; Naidu P; Rom L; Hidaka H; Marais AD; Jadhav A; Naoumova RP; Thompson GR
J Lipid Res; 1998 May; 39(5):1046-54. PubMed ID: 9610772
[TBL] [Abstract][Full Text] [Related]
38. The effect of abnormal plasma and cellular sterol content and composition on low density lipoprotein uptake and degradation by monocytes and lymphocytes in sitosterolemia with xanthomatosis.
Nguyen LB; Shefer S; Salen G; Horak I; Tint GS; McNamara DJ
Metabolism; 1988 Apr; 37(4):346-51. PubMed ID: 3357417
[TBL] [Abstract][Full Text] [Related]
39. Localization of 3-hydroxy-3-methylglutaryl CoA reductase and 3-hydroxy-3-methylglutaryl CoA synthase in the rat liver and intestine is affected by cholestyramine and mevinolin.
Li AC; Tanaka RD; Callaway K; Fogelman AM; Edwards PA
J Lipid Res; 1988 Jun; 29(6):781-96. PubMed ID: 2902179
[TBL] [Abstract][Full Text] [Related]
40. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.
Ketomaki A; Gylling H; Miettinen TA
J Lab Clin Med; 2004 Apr; 143(4):255-62. PubMed ID: 15085084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
